First oral monotherapy for patients with paroxysmal nocturnal haemoglobinuria EMA has recommended granting a marketing authorisation in the European Union (EU) for Fabhalta (iptacopan), an oral…
We value your input and always appreciate feedback. Your suggestions and comments help us improve our services, ensuring that we consistently meet your needs and exceed your expectations.
MO - FR 9:00 am - 5:00 pm |
|
Czech Republic, |